Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Klimator and Volvo Group initiates proof-of-value project in North America

Klimator will perform a proof-of-value project through the CampX by Volvo Group startup innovation hub in the US during Q4 2023, focusing on Klimator’s road weather information solution. The project has been granted financing of approximately 200 KSEK through the program FFI Accelerate Startup Partnership.The overall goal is to provide the driver with local weather hazards to improve driver experience and enable safer routing. The information will be visualized in a map through Klimator’s predictive cloud-based solution Road Condition Data, RCD, which enables the driver to get information

Calliditas to present at upcoming investor conferences

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that management will present at and participate in the following conferences: · The Jefferies London Healthcare Conference, November 14-16 2023, in London, UK. CEO Renee Aguiar-Lucander will present at 2pm GMT on Wednesday 15 November. · The Stifel Healthcare Conference 2023, November 15 2023, in New York, USA.President of North America, Andrew Udell, will take part in a fireside chat at 10:10am ET on Wednesday 15 November. · The SEB Healthcare Seminar, November 21 2023, in Stockholm,

Immunovia successfully completes discovery phase of next-generation test development

LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, today announced the successful completion of the discovery phase for the Company’s next-generation test.     The discovery study, which marks a key milestone in the development of Immunovia’s next-generation test to detect early-stage pancreatic cancer, successfully found more than a dozen proteins circulating in the blood that identified pancreatic ductal adenocarcinoma (PDAC) stage I and stage II patients.  The study is the most comprehensive pancreatic

Borr Drilling Limited – Invitation to webcast and conference call Q3 2023 results

Borr Drilling Limited (NYSE and OSE: BORR) plans to release its financial results for the third quarter 2023 on Thursday, November 16, 2023. A conference call and webcast is scheduled for 15:00 CET (9:00 AM New York Time) and participants are encouraged to dial in 10 minutes before the start of the call.  The earnings report and presentation will be available from the Investor Relations section on www.borrdrilling.com. In order to listen to the presentation, you may do one of the following: a)    Webcast To access the webcast, please go to the following link:https://edge.media-

Calmark receives Notice of Allowance regarding patent in USA

Calmark Sweden AB (publ) announces today that the US Patent Office ("USPTO") has issued a so-called Notice of Allowance regarding Calmark's test cassette and the construction of volume control, so-called 'Exact fill'The patent with the title "Exact fill" and application number 17/254609 covers the design of the test cassette for volume control of the blood sample amount. The patent provides protection until 2040. The Notice of Allowance means that the USPTO will approve the company's patent application. Including the new patent, Calmark owns 20 patents and 11 design protections regarding

HydrogenPro ASA – Notice of transaction by PDMR

7 November 2023 - HydrogenPro (the "Company") (OSE: HYPRO): Jardis Invest AS, being a company closely associated with Jarle Dragvik, CEO of the Company, has today purchased 33,333 shares in the Company at a price per share of NOK 14.78. After the transaction, Jarle Dragvik controls a total of 41,033 shares in the Company. Please see the attached form for further details. For additional information, please contact:Ida Eilertsen Nygård, Head of Investor Relations and ESGEmail: ir@hydrogen-pro.com Phone: +47 986 11 952 About HydrogenPro ASAHydrogenPro is a technology company

Correction: Interim report, January–September 2023

Re-submitting to include MAR disclaimer in press release footer. There is no change to the attached report.   July–September 2023 · Net sales increased by 1 percent to SEK 7,265m (7,196). · Gross profit increased by 3 percent to SEK 2,433m (2,361). · EBITDA rose by 5 percent to SEK 848m (808). · Adjusted EBITDA[1] increased by 5 percent to SEK 943m (901). · Profit after tax for the quarter was SEK 46m (-4,765). · Basic earnings per share were SEK 0.05 (-5.69) and diluted earnings per share were SEK 0.05 (-5.69). · Cash flow from operating activities was SEK 862m (

Multiconsult is the main designer on the Railway project Furnesbakken - Stange

Multiconsult (Oslo: MULTI) has been selected as main designer for the new double track railway project Furnesbakken – Stange in Stange municipality within Innlandet county, Norway. Hæhre Entreprenør AS has been nominated as the preferred contractor with Multiconsult as the main designer.The new railway is a part of the InterCity line Oslo – Hamar and will contribute to reduced travel time to less than one hour between the two cities with two trains per hour, and in addition increased capacity for long-distance trains including freight train transport. Multiconsult will be responsible for

Roboquest 1.0 is now live on Steam®, Xbox Series X|S, Xbox Game Pass and Epic Games Store

Developer RyseUp Studios and publisher Starbreeze Entertainment today announce that Roboquest  version 1.0 is now live and available on Steam®, Xbox Series X|S, Xbox Game Pass and Epic Games Store, retailing at $24.99. Cross-platform is enabled across all platforms. During its 3 year run in Early Access, Roboquest has managed to maintain a 94 percent positive rating and recently reached an overwhelmingly positive rating of 98 percent on Steam – just in time for release! Roboquest is releasing with a celebratory launch discount

Calmark ships instruments to India for a method comparison study

Calmark Sweden AB announces today that they are sending 2 units with associated bilirubin test cassettes to the distributor r2 Diagsnostics in India. The distributor plans to use the products for a method comparison.Calmark, together with r2 Diagnostics, has been working for a long time for a registration of Calmark Neo – Bilirubin on the Indian market. r2 Diagnostics plans to carry out a method comparison at state-accredited laboratories in the country. The result of the method comparison will be submitted to the registration authority in India as a supplement to other submitted material.

Director/PDMR Shareholding

Fidelity Special Values PLC Director Shareholding The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation 1 Details of the person discharging managerial  responsibilities / person closely associated  a) Name Mr Nigel Foster     2 Reason for the notification    a) Position/status Non-executive director (PDMR)     b) Initial notification Initial notification /Amendment    3 Details of the issuer, emission

Notification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä Corporation

Wärtsilä Corporation, flagging notification, 7 November 2023 at 15:30 EETNotification in accordance with the Finnish Securities Market Act Chapter 9 § 5: BlackRock, Inc.’s holding in Wärtsilä CorporationBlackRock, Inc. has informed Wärtsilä Corporation that it has crossed above the 5% disclosure limit on total holding in shares and voting rights on 6 November 2023. Following the transaction, BlackRock, Inc. owns 5.07% of Wärtsilä’s shares and voting rights, while its total holding in Wärtsilä Corporation corresponds to 5.28%. Total position of BlackRock, Inc. and its funds subject to

Wulff Group Plc: Manager Transaction – Lauri Sipponen

MANAGERS’ TRANSACTIONS | NOVEMBER 7, 2023 AT 3.30 P.M. Wulff Group Plc has received a notification from Lauri Sipponen, Wulff Group Plc’s Board of Directors Member, of a transaction made with its financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given in the table below. Name: Lauri SipponenPosition: Board of Directors MemberIssuer: Wulff Group PlcLEI: 74370016PW2V4W02LX91Notification type: Initial notificationReference

Eevia Health Plc gained significant new sales opportunities from key US tradeshow

Eevia Health Plc (”Eevia” or ”The Company”) concluded a successful tradeshow exhibition at the Supply Side West in Las Vegas, USA. The proceeds from the tradeshow are over 30 new leads and a range of significant sales opportunities, some of which are now being converted to sales contracts.Eevia executed a successful exhibition at the Supply Side West in Las Vegas. This show is rated by management as the best in the history of the Company. Eevia held more than 40 meetings over two days with prominent nutraceutical brands and manufacturers. The interest for the company has never been as

Swedish authority uses option, worth SEK 13.7 million, from a previous agreement with Advenica

Advenica has received an order regarding an option for continued new development of crypto products – an option that has been used by the Swedish authority that placed the original order. This original order came on June 28, 2021 and more information can be found in the press release from Advenica from this day.Advenica is a well-established and trusted supplier of cybersecurity solutions both in Sweden and internationally. The solutions are based on Advenica's patented technology and meet the authority's requirements for being able to communicate information that is classified up to TOP

Introducing WSC Whale Chart - the first global navigational aid to protect whales launched at International Whales Protection Workshop

Washington D.C./Geneva, 7 November 2023 – Accidental collisions between ships and whales are a global concern, and can occur wherever there is an overlap between whale activity and vessel traffic. To help seafarers plan their voyages to minimize the risk of collisions, the World Shipping Council (WSC) is today launching the WSC Whale Chart. This navigational aid is the first global mapping of all mandatory and voluntary governmental measures to reduce harm to whales from ships. The WSC Whale Chart is available for free  to all interested parties and will

Everysport Group publishes Interim Report for Q3 2023 on November 9, 2023

The Board of Directors of Everysport Group has today decided that the interim report for the third quarter of 2023 will be published at 08.00 a.m. on November 9. The Group had previously postponed the report due to the divestment of the company's operations in horse racing and betting and at the time ongoing negotiations linked to the company's strategic review of Every Padel. For more information, please contact:Hannes Andersson, CEO, Everysport Group ABPhone: +46 70 736 56 25E-mail: hannes.andersson@everysport.com About Everysport Group (publ)Everysport Group is a Swedish

Notice to extraordinary general meeting in Speqta AB (publ)

  The shareholders of Speqta AB (publ), reg. no. 556710–8757 (the “Company”), are hereby invited to an extraordinary general meeting on Friday, 24 November 2023 at 10:00, at Setterwalls Advokatbyrå at Sturegatan 10 in Stockholm. Registration for the meeting commence at 09:30. Notification Shareholders who wish to attend the meeting shall:   · both be listed as shareholder in the register of shareholders kept by Euroclear Sweden AB (the Swedish Central Securities Depository) concerning the circumstances on Thursday, 16 November 2023, and · not later than Monday,

Shareholders’ Nomination Board’s proposals regarding the composition and remuneration of Metso’s Board of Directors

Metso Corporation’s stock exchange release on November 7, 2023, at 3:00 p.m. EETThe Shareholders’ Nomination Board of Metso Corporation will propose to the Annual General Meeting, planned to be held on April 25, 2024, that the Board of Directors would have nine members and that all its current members - Brian Beamish, Klaus Cawén, Terhi Koipijärvi, Niko Pakalén, Ian W. Pearce, Reima Rytsölä, Emanuela Speranza, Kari Stadigh, and Arja Talma - would be re-elected.The Nomination Board will also propose that Kari Stadigh would be re-elected Chair of the Board and Klaus Cawén Vice Chair.All

NYAB Oyj - Managers' Transactions

NYAB PlcMANAGERS' TRANSACTIONS07 November 2023 at 15:00NYAB Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: PM Ruukki OyPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Markku KankaalaPosition: Member of the BoardIssuer: NYAB OyjLEI: 743700UX7WTIOT3QO547Notification type: INITIAL NOTIFICATIONReference number: 42773/4/4 ____________________________________________Transaction date: 2023-11-07Outside a trading venue

entourage appoints Jill Jiao as Account Director

entourage, the leading live communications agency recognized for creating exceptional bespoke experiences and campaigns using the power of storytelling, proudly welcomes Jill Jiao as Account Director. In her capacity in entourage, Jill will be leading the Aramco account.Jill brings over 17 years of experience in event management, communications, and client servicing, garnered while working across Asia, USA, Europe, and the Middle East. Her experience has shaped her into an excellent project manager and an even better team leader. In her role at entourage, Jill will be leading on servicing

Clinical Laserthermia Systems Announces Initiation of Prostate Cancer Clinical Study in collaboration with U.S based HALO Diagnostics

Lund, Sweden – November 7, 2023 – Clinical Laserthermia Systems AB (publ) (“CLS” or “the Company”) today announces that their US subsidiary CLS Americas and US based HALO Diagnostics, a leader in precision diagnostics and image-guided therapies (HALO Dx), has entered an agreement to initiate a clinical study using the TRANBERG Thermal Therapy System to perform image-guided focal laser ablation (FLA) of low-to-intermediate risk prostate cancer in 25 patients.Data from these patients treated over the next 6-8 months will be entered into a patient registry where their long-term follow up will

Fondia Plc: Managers' Transactions - Harri Savolainen

Fondia PlcManagers’ Transactions7.11.2023 at 2.00 p.m. EET Person subject to the notification requirementName: Harri SavolainenPosition: Chief Executive OfficerIssuer: Fondia OyjLEI: 7437001EYNE2OP789M37Notification type: INITIAL NOTIFICATIONReference number: 42739/5/4____________________________________________Transaction date: 2023-11-03Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)Instrument type: SHAREISIN: FI4000232913Nature of transaction: ACQUISITION Executed under portfolio or asset managementTransaction details(1): Volume: 1315 Unit price: 6.08

There are no items matching the current filter
There are no more items matching the current filter
Back to top